...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Budd-Chiari syndrome in a young female with factor V Leiden mutation: Successful treatment with lepirudin, a direct thrombin inhibitor
【24h】

Budd-Chiari syndrome in a young female with factor V Leiden mutation: Successful treatment with lepirudin, a direct thrombin inhibitor

机译:一名患有V型莱顿突变的年轻女性的Budd-Chiari综合征:直接凝血酶抑制剂lepirudin成功治疗

获取原文

摘要

Tfhrombotic etiologies are the most common in hepatic venous outflow obstruction, Budd-Chiari syndrome (BCS) . BCS usually affects young adults, associates with hematologic diseases (poly-cythemia vera, paroxysmal nocturnal hemoglobinuria, and thrombophilia) and thrombotic triggers including oral contraceptives, pregnancy, and cancer [1-3]. Diagnosis of possible underlying hematologic disorder is necessary for targeted early treatment#
机译:血栓形成的病因是最常见的肝静脉流出道梗阻,即Budd-Chiari综合征(BCS)。 BCS通常影响年轻人,并伴有血液系统疾病(真性红细胞增多症,阵发性夜间血红蛋白尿和血栓形成)和血栓触发因素,包括口服避孕药,妊娠和癌症[1-3]。对于有针对性的早期治疗,必须诊断可能的潜在血液学疾病#

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号